J&J Doubles Down On Orthopedics With Synthes Deal; Takes Lead In Trauma

Johnson & Johnson will control a majority of the orthopedic trauma device market and double its stake in the spinal device field by acquiring Synthes for $21.3 billion under a definitive agreement announced April 27.